[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558630":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":19,"interventions":25,"overallOfficials":31,"centralContacts":35,"locations":43,"responsibleParty":91,"collaborators":13,"id":93,"slug":94,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":13,"eligibilityCriteria":99,"healthyVolunteers":95,"sex":100,"minAge":13,"maxAge":13,"enrollmentInfo":101,"targetDuration":104,"studyType":105,"phases":13,"briefSummary":106,"conditions":107,"keywords":13,"overallStatus":46,"whyStopped":13,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Boston Scientific Corporation","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Change in patient's quality of life (QoL) during the study as compared with baseline","Change in quality of life assessments during the study as compared with baseline","Up to 24-Months",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"COHORT","PROSPECTIVE","The objective of this study is to compile real-world outcomes of Boston Scientific Corporation commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.","Patients planned to receive treatment with a commercially approved Boston Scientific RF system to create lesions in the central nervous system (CNS) for use in functional neurosurgery.",[20],{"label":21,"type":13,"description":22,"interventionNames":23},"Boston Scientific Radiofrequency Ablation Systems","Subjects treated with Boston Scientific commercially approved radiofrequency (RF) ablation systems in the central nervous system (CNS).",[24],"Device: Radiofrequency Ablation",[26],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":13},"DEVICE","Radiofrequency Ablation","Radiofrequency Ablation used in the central nervous system (CNS) in functional neurosurgery",[21],[32],{"name":33,"affiliation":5,"role":34},"Natalie M Bloom Lyons, M.A.","STUDY_DIRECTOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":13,"email":40},"Stephanie Delvaux","CONTACT","855-213-9890","BSNClinicalTrials@bsci.com",{"name":42,"role":38,"phone":39,"phoneExt":13,"email":40},"Diane Keesey",[44,59,69,79],{"facility":45,"status":46,"city":47,"state":13,"zip":13,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Uniklinik Köln","RECRUITING","Cologne","Germany","DE",{"type":51,"coordinates":52},"Point",[53,54],6.95,50.93333,{"lat":54,"lon":53},[57],{"name":58,"role":38,"phone":39,"phoneExt":13,"email":40},"Boston Scientific Clinical Research",{"facility":60,"status":46,"city":61,"state":13,"zip":13,"country":48,"countryCode":49,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Universitaetsklinikum Dusseldorf","Düsseldorf",{"type":51,"coordinates":63},[64,65],6.77927,51.22319,{"lat":65,"lon":64},[68],{"name":58,"role":38,"phone":39,"phoneExt":13,"email":40},{"facility":70,"status":46,"city":71,"state":13,"zip":13,"country":48,"countryCode":49,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Universitaetsklinikum Wuerzburg","Würzburg",{"type":51,"coordinates":73},[74,75],9.95121,49.79391,{"lat":75,"lon":74},[78],{"name":58,"role":38,"phone":39,"phoneExt":13,"email":40},{"facility":80,"status":46,"city":81,"state":13,"zip":13,"country":82,"countryCode":83,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"St. Georges Hospital","London","United Kingdom","UK",{"type":51,"coordinates":85},[86,87],-0.12574,51.50853,{"lat":87,"lon":86},[90],{"name":58,"role":38,"phone":39,"phoneExt":13,"email":40},{"type":92,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100558630","radiofrequency-rf-ablation-prospective-outcomes-study-for-central-nervous-system---rapid-for-cns-100558630",false,"NCT06553625","Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS","Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System","Inclusion Criteria:\n\n* Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU)\n* Signed a valid, IRB\u002FEC\u002FREB-approved informed consent form\n\nExclusion Criteria:\n\n* Meets any contraindications per locally applicable Directions for Use (DFU)\n* Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments","ALL",{"count":102,"type":103},200,"ESTIMATED","24 Months","OBSERVATIONAL","The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.",[108,109,110,111],"Parkinson Disease","Dystonia","Essential Tremor","Movement Disorders","2026-09-10",{"date":114,"type":115},"2026-09-11","ACTUAL",{"date":117,"type":115},"2024-01-29",{"date":119,"type":103},"2035-12",{"name":5,"class":6},4]